Risk Factors for the Development of Early Recurrence in Patients with Primary Retroperitoneal Sarcoma.
Fabio TirottaMichael G FadelMarco BaiaAlessandro ParenteValentina MessinaPaul BassettL Max AlmondSamuel J FordAnant DesaiWinan J van HoudtDirk C StraussPublished in: Annals of surgical oncology (2023)
Early recurrence is associated with a poor prognosis, and a high tumor grade is an independent predictor for the development of EREC. Patients with EREC may benefit the most from new therapeutic options such as neoadjuvant chemotherapy.